A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is strongly associated with the human leukocyte antigen (HLA)-DRB1 locus that possesses the shared susceptibility epitope (SE) and the citrullination of self-antigens. We show how citrullinated aggrecan and vimentin epitopes bind to HLA-DRB1*04:01/04. Citrulline was accommodated within the electropositive P4 pocket of HLA-DRB1*04:01/04, whereas the electronegative P4 pocket of the RA-resistant HLA-DRB1*04:02 allomorph interacted with arginine or citrulline-containing epitopes. Peptide elution studies revealed P4 arginine–containing peptides from HLA-DRB1*04:02, but not from HLA-DRB1*04:01/04. Citrullination altered protease susceptibility of vimentin, thereby generating self-epitopes that are presented to T cells in HLA-DRB1*04:01+ individuals. Using HLA-II tetramers, we observed citrullinated vimentin- and aggrecan-specific CD4+ T cells in the peripheral blood of HLA-DRB1*04:01+ RA-affected and healthy individuals. In RA patients, autoreactive T cell numbers correlated with disease activity and were deficient in regulatory T cells relative to healthy individuals. These findings reshape our understanding of the association between citrullination, the HLA-DRB1 locus, and T cell autoreactivity in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599 · cited 3×
“Alleles having this shared conserved region of the DR 70–74 region are termed to have a shared susceptibility epitope (SE; Gregersen et al., 1987) and include the commonly occurring HLA DRB1*04:01, *04:04, and *01:01 molecules.”
BackgroundInfluentialMiyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291 · cited 2×
“…and activated CD45RAFoxp3+CD25hi suppressive populations (regulatory T [T reg] cells), and Foxp3loCD45RA and Foxp3-CD45RA+ and CD45RA nonsuppressive populations, which each have potential for proinflammatory cytokine production upon stimulation ex vivo (Miyara et al., 2009, 2011).”
BackgroundEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Raychaudhuri, S., Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1076 · Cited by 946 · cited 4×
“1.6 1.9 2.1 1.3 1 1.8 1.8 aRp.i.m = hkl [1/(N 1)]1/2 i | Ihkl, i <Ihkl> | / hkl <Ihkl> bRfactor = ( | |Fo| |Fc|”
BackgroundInfluentialKlareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
A time- and cost-efficient system for high-level protein production in mammalian cells
Aricescu, A. R., Lu, W., & Jones, E. Y. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906029799 · Cited by 762 · cited 2×
“The extracellular domains of the HLA-DR4 (DRA*01:01/DRB1*04:01, *04:02, and *04:04) and chains were cloned into the pHLsec (Aricescu et al., 2006) vector for expression in HEK 293S (GnTI) cells (Reeves et al., 2002).”
MethodImproved visualization of protein consensus sequences by iceLogo
Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., & Gevaert, K. (2009) · Nature Methods · doi:10.1038/nmeth1109-786 · Cited by 741
Cited by
10 Years of GWAS Discovery: Biology, Function, and Translation
Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A., & Yang, J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.005 · Cited by 3,719
“Through the use of amino acid imputation and association studies, this ‘‘shared epitope’’ sequence was extended,(112) and this information used to provide a molecular explanation for the propensity of peptides with citrullinated component amino acids to induce disease.(113) HLA variants have long been known to be majo…”
MethodImmunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)
Klein, L., Kyewski, B., Allen, P. M., & Hogquist, K. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3667 · Cited by 1,383
Immunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
“Subsequent crystal studies have characterized in detail the nature of the citrullinated peptide binding to HLADRB1 (Scally et al., 2013).”
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
“94 95 The majority of human tumors are not driven by active viral infections.”
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Dendrou, C. A., Petersen, J., Rossjohn, J., & Fugger, L. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.143 · Cited by 787
Self-citationThe multifactorial role of neutrophils in rheumatoid arthritis
Wright, H. L., Moots, R. J., & Edwards, S. W. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.80 · Cited by 590
Konig, M. F., Abusleme, L., Reinholdt, J., Palmer, R. J., Teles, R. P., Sampson, K., Rosen, A., Nigrovic, P. A., Sokolove, J., Giles, J. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj1921 · Cited by 588
Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis
van der Woude, D., & van der Helm-van Mil, A. H. M. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.10.005 · Cited by 479
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Malmström, V., Catrina, A. I., & Klareskog, L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.124 · Cited by 451
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis
Conforti, A., Di Cola, I., Pavlych, V., Ruscitti, P., Berardicurti, O., Ursini, F., Giacomelli, R., & Cipriani, P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102735 · Cited by 407
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Fugger, L., Jensen, L. T., & Rossjohn, J. (2020) · Cell · doi:10.1016/j.cell.2020.03.007 · Cited by 398
Self-citationBenham, H., Nel, H. J., Law, S. C., Mehdi, A. M., Street, S., Ramnoruth, N., Pahau, H., Lee, B. T., Ng, J., G. Brunck, M. E., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9301 · Cited by 379
Self-citationMass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 354
Self-citationAutoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Suurmond, J., & Diamond, B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78084 · Cited by 337
“In RA, one of the genetic risk HLA alleles, HLA-DRB1*0401, has recently been associated with presentation of citrullinated peptides, allowing for activation of citrulline-specific T cells (22).”
BackgroundThe role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
“antigen complex found that SE alleles preferentially bound citrullinated peptides, whereas other alleles bound both citrulline and arginine [8].”
BackgroundCarmona-Rivera, C., Carlucci, P. M., Moore, E., Lingampalli, N., Uchtenhagen, H., James, E., Liu, Y., Bicker, K. L., Wahamaa, H., Hoffmann, V., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aag3358 · Cited by 309
Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.026 · Cited by 309
“A subset of tetramer-positive CD4+ T cells in the first 35 days following primary vaccination exhibited an activated surface phenotype characterized by upregulation of both CD38 and HLA-DR (Figure 3D).”
InfluentialSelf-citationThe Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease
Spagnolo, P., Lee, J. S., Sverzellati, N., Rossi, G., & Cottin, V. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40574 · Cited by 306
“In patients who also possess the SE, citrullinated residues may act as neoepitopes that break immunologic tolerance and become a target for autoimmunity (24,25).”
BackgroundFresneda Alarcon, M., McLaren, Z., & Wright, H. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649693 · Cited by 278
“Presentation of citrullinated antigens to autoreactive T cells provides a molecular explanation for the strong association between the HLA-DRB1∗04:01/04 allele and the development of RA (164, 167).”
BackgroundHu, X., Deutsch, A. J., Lenz, T. L., Onengut-Gumuscu, S., Han, B., Chen, W.-M., Howson, J. M. M., Todd, J. A., de Bakker, P. I. W., Rich, S. S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3353 · Cited by 271
Variations in MHC Class II Antigen Processing and Presentation in Health and Disease
Unanue, E. R., Turk, V., & Neefjes, J. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055420 · Cited by 270
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
Wang, J., Jelcic, I., Mühlenbruch, L., Haunerdinger, V., Toussaint, N. C., Zhao, Y., Cruciani, C., Faigle, W., Naghavian, R., Foege, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.054 · Cited by 268
Chemin, K., Gerstner, C., & Malmström, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00353 · Cited by 237
“Such peptide presentation has indeed been demonstrated both functionally (10) and by peptide-HLA crystal structure determination (11).”
BackgroundDominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
Ooi, J. D., Petersen, J., Tan, Y. H., Huynh, M., Willett, Z. J., Ramarathinam, S. H., Eggenhuizen, P. J., Loh, K. L., Watson, K. A., Gan, P. Y., et al. (2017) · Nature · doi:10.1038/nature22329 · Cited by 218
Self-citationChapman, E. A., Lyon, M., Simpson, D., Mason, D., Beynon, R. J., Moots, R. J., & Wright, H. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00423 · Cited by 204
“Many citrullinated host proteins act as sources of autoantigens in RA; for example citrulline residues in aggrecan and vimentin are preferentially recognized by antigen-presenting cells in individuals carrying the HLA-DRB104:01/04 allele (which contains the “shared susceptibility epitope”) (124).”
BackgroundEtiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review
Romão, V. C., & Fonseca, J. E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.689698 · Cited by 193
“Subsequent demonstration that both activity and expression of the citrullination enzyme PAD2 are increased in the bronchioalveolar compartment of smokers (210) and that, after citrullination, peptides such as vimentin or fibrinogen bind specifically to SE-containing HLA molecules and induce the emergence of autoreacti…”
BackgroundInternational Serious Adverse Events Consortium, Heap, G. A., IBD Pharmacogenetics Study Group, Weedon, M. N., Bewshea, C. M., Singh, A., Chen, M., Satchwell, J. B., Vivian, J. P., So, K., et al. (2014) · Nature Genetics · doi:10.1038/ng.3093 · Cited by 190
Self-citationDendritic cells, T cells and their interaction in rheumatoid arthritis
Wehr, P., Purvis, H., Law, S.-C., & Thomas, R. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13256 · Cited by 189
Self-citationHuman Leukocyte Antigen–Disease Associations in Rheumatoid Arthritis
van Drongelen, V., & Holoshitz, J. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.04.003 · Cited by 177
Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes
Rondas, D., Crèvecoeur, I., D’Hertog, W., Ferreira, G. B., Staes, A., Garg, A. D., Eizirik, D. L., Agostinis, P., Gevaert, K., Overbergh, L., et al. (2015) · Diabetes · doi:10.2337/db14-0621 · Cited by 156
“These citrullinated peptide epitopes are better accommodated in the HLA pocket of HLA-DR4–type individuals, determining the strength of the immune response to citrullinated peptides and providing a molecular basis for the genetic predisposition of HLA-DR4 individuals to RA (34).”
BackgroundHuman neutrophils in auto-immunity
Thieblemont, N., Wright, H. L., Edwards, S. W., & Witko-Sarsat, V. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.004 · Cited by 173
Wysocki, T., Olesińska, M., & Paradowska‐Gorycka, A. (2020) · Cells · doi:10.3390/cells9051127 · Cited by 172
“HLA-DRB1 Allele Influence on RA Risk P4 Pocket Charge Preference for Cit over Arg Binding Amino Acid Specificity Binding Affinity of Selected RA Epitopes Reference Vim-64,69,71Cit (59–71) Vim-71Cit (66–78) CII1240Cit *0401 risk allele positive P4; other unknown no low high high [38,83]”
BackgroundReview: Genetics and the Classification of Arthritis in Adults and Children
Nigrovic, P. A., Raychaudhuri, S., & Thompson, S. D. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40350 · Cited by 168
Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis
Catrina, A. I., Ytterberg, A. J., Reynisdottir, G., Malmström, V., & Klareskog, L. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.115 · Cited by 167
(2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337corr1 · Cited by 139
Autophagy: controlling cell fate in rheumatic diseases
Rockel, J. S., & Kapoor, M. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.92 · Cited by 161
Mechanisms involved in triggering rheumatoid arthritis
Catrina, A. I., Joshua, V., Klareskog, L., & Malmström, V. (2016) · Immunological Reviews · doi:10.1111/imr.12379 · Cited by 160
“Still, such a scenario is indirectly supported by the fact that citrulline-reactive T cells may be found in the peripheral T-cell repertoire of healthy individuals carrying the HLA-DR alleles associated with RA (98, 101, 102), and hence have not been deleted during thymic selection.”
BackgroundBeyond citrullination: other post-translational protein modifications in rheumatoid arthritis
Trouw, L. A., Rispens, T., & Toes, R. E. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.15 · Cited by 160
Self-citationT cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex
Beringer, D. X., Kleijwegt, F. S., Wiede, F., van der Slik, A. R., Loh, K. L., Petersen, J., Dudek, N. L., Duinkerken, G., Laban, S., Joosten, A., et al. (2015) · Nature Immunology · doi:10.1038/ni.3271 · Cited by 135
Self-citationMass spectrometry-based antigen discovery for cancer immunotherapy
Bassani‐Sternberg, M., & Coukos, G. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.04.005 · Cited by 148
Holmdahl, R., Malmström, V., & Burkhardt, H. (2014) · European Journal of Immunology · doi:10.1002/eji.201444486 · Cited by 139
Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment
Sakkas, L. I., Bogdanos, D. P., Katsiari, C. G., & Platsoucas, C. D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.012 · Cited by 138
The autoimmunity–oral microbiome connection
Nikitakis, N. G., Papaioannou, W., Sakkas, L. I., & Kousvelari, E. E. (2016) · Oral Diseases · doi:10.1111/odi.12589 · Cited by 138
Klareskog, L., Rönnelid, J., Saevarsdóttir, S., Padyukov, L., & Alfredsson, L. S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13058 · Cited by 138
Zhou, Y., Chen, B., Mittereder, N., Chaerkady, R., Strain, M. D., An, L.-L., Rahman, S., Ma, W., Low, C. P., Chan, D. T. Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01200 · Cited by 136
“The roles of PADs and their enzymatic activity in RA is supported by genetic evidence which has shown that PAD2 and PAD4 SNPs are associated with RA susceptibility (20–22), and the RA-associated HLA-DRB1 susceptibility alleles have been shown to present citrullinated antigens more efficiently (23).”
BackgroundRuiz-Ballesteros, A. I., Meza-Meza, M. R., Vizmanos-Lamotte, B., Parra‐Rojas, I., & la Cruz-Mosso, U. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249626 · Cited by 136
“Among these, HLA-DRB1 was associated with genetic susceptibility and modulation of clinical manifestations severity of MS [23,24], RA [25], and SLE [26].”
BackgroundGene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis
Catrina, A. I., Deane, K. D., & Scher, J. U. (2014) · Rheumatology · doi:10.1093/rheumatology/keu469 · Cited by 136
The association between rheumatoid arthritis and periodontitis
Leech, M. T., & Bartold, P. M. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.03.001 · Cited by 129
Genetics of rheumatoid arthritis susceptibility, severity, and treatment response
Viatte, S., & Barton, A. C. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0630-4 · Cited by 129
“This observation implicates antigenic peptide presentation to T cells as key to disease causation [47].”
BackgroundPyTMs: a useful PyMOL plugin for modeling common post-translational modifications
Warnecke, A., Sandalova, T., Achour, A., & Harris, R. A. (2014) · BMC Bioinformatics · doi:10.1186/preaccept-1977987350137477 · Cited by 120
“The molecular basis of this association has only recently been characterized at a structural level [25].”
InfluentialAP-1 Expression and its Clinical Relevance in Immune Disorders and Cancer
Trop-Steinberg, S., & Azar, Y. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.01.019 · Cited by 128
Structural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and Autoimmunity
Clayton, G. M., Wang, Y., Crawford, F., Novikov, A., Wimberly, B. T., Kieft, J. S., Falta, M. T., Bowerman, N. A., Marrack, P., Fontenot, A. P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.048 · Cited by 124
“As structural information begins to accumulate for the actual targets of autoimmune diseases, enzymatic posttranslational modifications (Cordova et al., 2013; Scally et al., 2013; Sollid and Jabri, 2011) and organ-specific peptide processing have been implicated in generating the relevant ligands (Crawford et al.”
Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
Bendstrup, E. M., Møller, J., Kronborg-White, S. B., Prior, T. S., & Hyldgaard, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122038 · Cited by 123
“Anti-citrullinated protein antibodies (ACPAs) are synthesized in genetically predisposed individuals during inflammation; these antibodies are found in the majority of patients with RA [20].”
BackgroundTing, Y. T., Petersen, J., Ramarathinam, S. H., Scally, S. W., Loh, K. L., Thomas, R., Suri, A., Baker, D. G., Purcell, A. W., Reid, H. H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001013 · Cited by 105
“The cDNA encoding extracellular domains of HLADRB1*04:01/-HLA-DRB1*04:02/-HLA-DRB1*04:05 were separately cloned into the pHLsec expression vector with a sequence encoding an N-terminal covalently linked factor Xacleavable, Strep-tag MHC class II-associated invariant chain peptide (Strep-CLIP; WSHPQFEKGAPVSKMRMATPLLMQA…”
BackgroundMethodInfluentialSelf-citationNeutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis
O’Neil, L. J., Barrera‐Vargas, A., Sandoval-Heglund, D., Merayo‐Chalico, J., Aguirre-Aguilar, E., Aponte, A. M., Ruiz‐Perdomo, Y., Guček, M., El-Gabalawy, H. S., Fox, D. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd2688 · Cited by 114
HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors
Ishigaki, K., Lagattuta, K. A., Luo, Y., James, E. A., Buckner, J. H., & Raychaudhuri, S. (2022) · Nature Genetics · doi:10.1038/s41588-022-01032-z · Cited by 105
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis
Ciccia, F., Guggino, G., Rizzo, A., Manzo, A., Vitolo, B., Manna, M. P. L., Giardina, G., Sireci, G., Dieli, F., Montecucco, C., et al. (2015) · Rheumatology · doi:10.1093/rheumatology/kev252 · Cited by 113
Vimentin as antigenic target in autoimmunity: A comprehensive review
Musaelyan, A., Lapin, S., Nazarov, V., Tkachenko, O., Gilburd, B., Mazing, A., Mikhailova, L., & Shoenfeld, Y. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.004 · Cited by 111
T peripheral helper cells in autoimmune diseases*
Marks, K. E., & Rao, D. A. (2022) · Immunological Reviews · doi:10.1111/imr.13069 · Cited by 111
Gerstner, C., Dubnovitsky, A., Sandin, C., Kozhukh, G., Uchtenhagen, H., James, E. A., Rönnelid, J., Ytterberg, A. J., Pieper, J., Reed, E., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00494 · Cited by 104
“To our knowledge, only one study has hitherto provided insights in the structural features of citrullinated peptides in complex with HLA-DRB1*04:01, *04:02, and *04:04 (14).”
BackgroundMethodReynolds, G., Gibbon, J. R., Pratt, A. G., Wood, M. J., Coady, D., Raftery, G., Lorenzi, A. R., Gray, A., Filer, A., Buckley, C. D., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206578 · Cited by 91
Ishigaki, K., Shoda, H., Kochi, Y., Yasui, T., Kadono, Y., Tanaka, S., Fujio, K., & Yamamoto, K. (2015) · Scientific Reports · doi:10.1038/srep12937 · Cited by 102
Schinnerling, K., Rosas, C., Soto, L., Thomas, R., & Aguillón, J. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00203 · Cited by 101
“Particularly, peptides post-translationally modified by citrullination bind with high affinity to the SE, initiating citrulline-specific T and B cell responses (45, 46).”
BackgroundSelf-citationMolecular mechanisms for contribution of MHC molecules to autoimmune diseases
Sollid, L. M., Pos, W., & Wucherpfennig, K. W. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.08.005 · Cited by 100
Marré, M. L., McGinty, J. W., Chow, I., DeNicola, M., Beck, N. W., Kent, S. C., Powers, A. C., Bottino, R., Harlan, D. M., Greenbaum, C. J., et al. (2018) · Diabetes · doi:10.2337/db17-1166 · Cited by 100
“In rheumatoid arthritis, conversion of arginine to citrulline by peptidyl arginine deiminase (PAD) generates neoepitopes that are presented by disease-associated HLA-DR proteins (5).”
BackgroundT cells specific for post-translational modifications escape intrathymic tolerance induction
Raposo, B., Merky, P., Lundqvist, C., Yamada, H., Urbonaviciute, V., Niaudet, C., Viljanen, J., Kihlberg, J., Kyewski, B., Ekwall, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02763-y · Cited by 92
Abualrous, E. T., Sticht, J., & Freund, C. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.04.009 · Cited by 95
Neutrophils and arthritis: Role in disease and pharmacological perspectives
Fattori, V., Amaral, F. A., & Verri, W. A., Jr. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.027 · Cited by 94
.Robertson, C. C., & Rich, S. S. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.01.006 · Cited by 73
Buitinga, M., Callebaut, A., Sodré, F. M. C., Crèvecoeur, I., Blahnik-Fagan, G., Yang, M., Bugliani, M., Arribas-Layton, D., Marré, M. L., Cook, D. P., et al. (2018) · Diabetes · doi:10.2337/db18-0295 · Cited by 90
Paulín, F., Doyle, T. J., Fletcher, E. A., Ascherman, D. P., & Rosas, I. O. (2015) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00249-9 · Cited by 89
Miyadera, H., & Tokunaga, K. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.100 · Cited by 88
HLA and kidney disease: from associations to mechanisms
Robson, K. J., Ooi, J. D., Holdsworth, S. R., Rossjohn, J., & Kitching, A. R. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0057-8 · Cited by 87
Self-citationT Cell Epitopes and Post-Translationally Modified Epitopes in Type 1 Diabetes
McGinty, J. W., Marré, M. L., Bajzik, V., Piganelli, J. D., & James, E. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0657-7 · Cited by 77
The function of myeloid dendritic cells in rheumatoid arthritis
Yu, M. B., & Langridge, W. H. R. (2017) · Rheumatology International · doi:10.1007/s00296-017-3671-z · Cited by 86
“These native peptides cannot be loaded onto HLA-DR due to electrostatic repulsion, but the repulsion is minimized when citrullination converts positively charged arginine into neutral citrulline [58].”
BackgroundThe Infectious Basis of ACPA-Positive Rheumatoid Arthritis
Sakkas, L. I., Daoussis, D., Liossis, S. C., & Bogdanos, D. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01853 · Cited by 86
“Indeed, citrullination increases the affinity of citrullinated antigen to HLA-DRB1SE allele (Hill et al., 2003; Scally et al., 2013).”
BackgroundResultInfluentialHLA associations in inflammatory arthritis: emerging mechanisms and clinical implications
Busch, R., Kollnberger, S., & Mellins, E. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0219-5 · Cited by 85
Jacob, J., Song, J. W., Yoon, H., Cross, G., Barnett, J. L., Woo, W. L., Adams, F., Kokosi, M. A., Devaraj, A., Renzoni, E. A., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.038 · Cited by 85
“…Packard et al., 2013) that may activate protein citrullination (Rocha-Muñoz et al., 2015;Makrygiannakis et al., 2008; Rangel-Moreno et al., 2006; Scally et al., 2013), oxidative stresses (Vuorinen et al., 2008; Volonte et al., 2009), andmatrix remodeling (Zandvoort et al., 2008) all of which…”
BackgroundMaisha, J. A., El-Gabalawy, H. S., & O’Neil, L. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221125 · Cited by 84
“Studies suggest that the SE binds to citrullinated peptides more efficiently than non-SE HLA-DRB1 variants (5).”
BackgroundImmune recognition of citrullinated epitopes
Nguyen, H. Q. T., & James, E. A. (2016) · Immunology · doi:10.1111/imm.12640 · Cited by 81
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79
Asteriou, E., Gkoutzourelas, A., Mavropoulos, Α., Katsiari, C. G., Sakkas, L. I., & Bogdanos, D. P. (2018) · Nutrients · doi:10.3390/nu10070908 · Cited by 79
“Convincing data have shown that citrullination amplifies the affinity of peptides to HLA-DRB1SE alleles [81,82].”
BackgroundHammer, C., Begemann, M., McLaren, P. J., Bartha, I., Michel, A., Klose, B., Schmitt, C., Waterboer, T., Pawlita, M., Schulz, T. F., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.008 · Cited by 78
“This figure was prepared with UCSF chimera,(14) with Protein Data Bank code PDB: 4MCY.(15)”
MethodOsteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis
Jung, Y., Kang, Y. M., & Han, S. W. (2019) · Immune Network · doi:10.4110/in.2019.19.e2 · Cited by 77
“Whereas the citrullinated peptides can have preferential but weak binding to HLA-DR proteins and it can make the citrullinated self-antigen-specific T cells escape the thymic negative selection (49,50).”
BackgroundCrosstalk between B cells and neutrophils in rheumatoid arthritis
Karmakar, U., & Vermeren, S. (2021) · Immunology · doi:10.1111/imm.13412 · Cited by 75
“The presence of two positively charged residue (lysine, arginine) in residues 71– 73 increases the binding capacity of citrullinated peptides over native peptides [72,73].”
BackgroundKim, K.-W., Jiang, X., Cui, J., Lü, B., Costenbader, K. H., Sparks, J. A., Bang, S., Lee, H., Okada, Y., Raychaudhuri, S., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39228 · Cited by 75
The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
Purcell, A. W., Sechi, S., & DiLorenzo, T. P. (2019) · Diabetes · doi:10.2337/dbi18-0066 · Cited by 74
“Posttranslational modification of antigens can impact the liberation of immunogenic epitopes during antigen processing (59), altering the spectrum of presented peptides.”
BackgroundSelf-citationImmune cell profiling to guide therapeutic decisions in rheumatic diseases
Ermann, J., Rao, D. A., Teslovich, N. C., Brenner, M. B., & Raychaudhuri, S. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.71 · Cited by 73
Sakurai, K., Ishigaki, K., Shoda, H., Nagafuchi, Y., Tsuchida, Y., Sumitomo, S., Kanda, H., Suzuki, A., Kochi, Y., Yamamoto, K., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.170909 · Cited by 73
Galea, R. C., Nel, H. J., Talekar, M., Liu, X., Ooi, J. D., Huynh, M., Hadjigol, S., Robson, K. J., Ting, Y. T., Cole, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126025 · Cited by 72
Self-citationCurran, A. M., Girgis, A. A., Jang, Y., Crawford, J. D., Thomas, M. A., Kawalerski, R. R., Coller, J., Bingham, C. O., Na, C. H., & Darrah, E. (2023) · Nature Communications · doi:10.1038/s41467-023-36620-y · Cited by 71
Le Guen, Y., Luo, G., Ambati, A., Damotte, V., Jansen, I., Yu, E., Nicolas, A., de Rojas, I., Peixoto Leal, T., Miyashita, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302720120 · Cited by 60
“S7) (33, 34).”
Effector CD4+ T cells recognize intravascular antigen presented by patrolling monocytes
Westhorpe, C. L. V., Norman, M. U., Hall, P., Snelgrove, S. L., Finsterbusch, M., Li, A., Lo, C. Y.-W., Tan, Z., Li, S., Nilsson, S. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03181-4 · Cited by 71
The immunopathogenesis of rheumatoid arthritis
Firestein, G. S. (1991) · Current Opinion in Rheumatology · doi:10.1097/00002281-199106000-00012 · Cited by 71
Jönsson, P., Southcombe, J. H., Santos, A. M., Huo, J., Fernandes, R. A., McColl, J. T., Lever, M., Evans, E. J., Hudson, A., Chang, V. T.-C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513918113 · Cited by 71
“sCD4 protein and soluble, biotinylatable forms of DR1/HA (residues 307–318:PKYVKQNTLKLA), DR2/ MBP (residues 85–99:ENPVVHFFKNIVTPR), DR4/EBV (residues 627–641: TGGVYHFVKKHVHES), and A24/Den2 (residues 555–564:INYADRRWCF) were produced as described previously (35, 36).”
MethodSelf-citationAnticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis
England, B. R., Thiele, G. M., & Mikuls, T. R. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000356 · Cited by 69
de Jong, A., Jabbari, A., Dai, Z., Xing, L., Lee, D., Li, M. M., Duvic, M., Hordinsky, M., Norris, D. A., Price, V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121949 · Cited by 64
Metadata
- Authors
- Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B. G., van Heemst, J., Pike, R. N., McCluskey, J., Toes, R. E., La Gruta, N. L., Purcell, A. W., Reid, H. H., Thomas, R., & Rossjohn, J.
- Affiliations
- Monash University (AU)
- Translational Research Institute (AU)
- The University of Melbourne (AU)
- Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, Netherlands 4
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia 3
- Corresponding author
- Purcell, Anthony W.
- Reid, Hugh H.
- Thomas, Ranjeny
- Rossjohn, Jamie
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-11-04
- Volume
- 210
- Issue
- 12
- Pages
- 2569-2582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3832918
- OpenAlex
- W2146707828
- Cited by
- 429
- References
- 59
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 27 · 2023: 42 · 2022: 25 · 2021: 31 · 2020: 33 · 2019: 41 · 2018: 36 · 2017: 41 · 2016: 48 · 2015: 35 · 2014: 25 · 2013: 1
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, HLA-DRB1, citrullination, citrullinated vimentin, HLA-DRB1*0401, peptide binding, autoreactive T cells, CD4+ T cells, regulatory T cells, disease activity, autoantigens
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Arthritis, Rheumatoid, Autoantigens, Citrulline, Humans, Mice, Transgenic, Models, Molecular, Molecular Sequence Data, Polymorphism, Genetic, Vimentin, CD4-Positive T-Lymphocytes, HLA-DR4 Antigen, Antigen Presentation, Mice, Aggrecans, Genetic Association Studies, HLA-DR beta-Chains, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.